enGene Holdings Inc.

NASDAQ:ENGN

Biotechnology

Healthcare
$1.85 -1.15%

-$0.02 today

Market cap
$123.98M
Beta
-0.29
P/E (TTM)
-1.8
EPS (TTM)
-$0.95
52W Low $1.40High $12.25

Volume 2.81M

Average 1.58M

Balance Sheet

Inspect the capital base behind the business.

Assets

$221.47M

FY 2025 · Annual

-28.8% YoY

Liabilities

$53.76M

FY 2025 · Annual

+39.4% YoY

Equity

$167.71M

FY 2025 · Annual

-38.5% YoY

Balance Sheet

USD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Cash & Equivalents1.07M314.15K81.52M173M50.15M
Short-term Investments0076K65.4M143.66M
Net Receivables002.34M1.03M2.23M
Inventory00000
Other Current Assets001.5M7.93M5.35M
Total Current Assets1.57M511.8K85.44M247.36M201.39M
Property, Plant & Equipment (Net)00589K2.91M10.19M
Goodwill00000
Intangible Assets00000
Long-term Investments129.67M131.53M70K59.53M8.52M
Tax Assets00000
Other Non-current Assets209.05K939K860K1.37M1.36M
Total Non-current Assets129.88M131.53M1.52M63.81M20.08M
Total Assets131.45M132.04M86.96M311.17M221.47M
Account Payables001.16M1.41M6.69M
Short-term Debt1.05M1.27M562K1.12M10.02M
Tax Payables022K39K00
Deferred Revenue00000
Other Current Liabilities327.45K893.51K2.69M8.65M11.2M
Total Current Liabilities327.45K893.51K5.26M14.66M31.98M
Long-term Debt009.22M22.47M15.32M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)3.73M0000
Other Non-current Liabilities03.73M000
Total Non-current Liabilities3.73M3.73M9.22M23.9M21.78M
Total Liabilities4.05M4.62M14.47M38.56M53.76M
Common Stock129.67M131.53M259.37M509.81M513.28M
Retained Earnings(2.28M)(4.11M)(199.59M)(254.73M)(372.03M)
Accumulated OCI00(1.02M)(1.42M)(888K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity127.39M127.42M72.49M272.61M167.71M
Total Debt4.16M32.11M9.78M25.02M31.8M
Net Debt(1.07M)(314.15K)(71.74M)(147.98M)(18.36M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$29.8M
Short-term Investments$228.6M
Receivables$2.9M
Other Current$8.6M
Total Current Assets$270.0M
PP&E (Net)$9.4M
Long-term Investments$26.7M
Other Non-current$1.4M
Total Non-current Assets$37.5M
Total Assets$307.5M

Analysis

Selected assets total $307.5M for Latest. The largest visible component is Short-term Investments at $228.6M, about 74.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
3Initial statement of beneficial ownershipNov 13, 2026
SC 13GSC 13G filingNov 13, 2026
8-KCurrent reportNov 12, 2026
4Statement of changes in beneficial ownershipSep 24, 2026

How much cash does ENGN have?

enGene Holdings Inc. (ENGN) reported $50.15M in cash and equivalents in fiscal 2025.

How much debt does ENGN carry?

enGene Holdings Inc. (ENGN) reported $31.80M of total debt, with net debt of -$18.36M.